| ANS | Average Normalized Score |
| BCa | Bladder Cancer |
| CIS | Carcinoma in situ |
| CSmiRTar | Condition-Specific miRNA Targets |
| DAVID | The Database for Annotation, Visualization, and Integrated Discovery |
| DGIdb | Drug–Gene Interaction Database |
| EORTC | The European Organization for Research and Treatment of Cancer |
| FDA | Food and Drug Administration |
| FFPE | Formalin-Fixed Paraffin-Embedded |
| HG | High grade |
| KEGG | The Kyoto Encyclopedia of Genes and Genomes |
| LG | Low grade |
| MFS | Metastasis-Free Survival |
| MIBC | Muscle-Invasive Bladder Cancer |
| miRNAs | microRNAs |
| NMIBC | Non-Muscle-Invasive Bladder Cancer |
| OS | Overall Survival |
| PCA | Principal Component Analysis |
| PFS | Progression-Free Survival |
| TURBT | Transurethral Resection Of The Bladder |